Quoin Pharmaceuticals Cash Per Share vs. Return On Asset

QNRX Stock  USD 0.30  0.01  3.23%   
Based on Quoin Pharmaceuticals' profitability indicators, Quoin Pharmaceuticals Ltd may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in April. Profitability indicators assess Quoin Pharmaceuticals' ability to earn profits and add value for shareholders.
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
13.65
Current Value
12.97
Quarterly Volatility
1.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to -45.87 in 2025. Days Sales Outstanding is likely to drop to -71.21 in 2025. At this time, Quoin Pharmaceuticals' Net Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 675 K in 2025, despite the fact that Operating Income is likely to grow to (8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.11.3
Fairly Down
Very volatile
For Quoin Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Quoin Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Quoin Pharmaceuticals Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Quoin Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Quoin Pharmaceuticals Ltd over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quoin Pharmaceuticals. If investors know Quoin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quoin Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.66)
Return On Assets
(0.44)
Return On Equity
(1.35)
The market value of Quoin Pharmaceuticals is measured differently than its book value, which is the value of Quoin that is recorded on the company's balance sheet. Investors also form their own opinion of Quoin Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Quoin Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quoin Pharmaceuticals' market value can be influenced by many factors that don't directly affect Quoin Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quoin Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quoin Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quoin Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Quoin Pharmaceuticals Return On Asset vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Quoin Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Quoin Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Quoin Pharmaceuticals Ltd is rated below average in cash per share category among its peers. It is rated third in return on asset category among its peers . At this time, Quoin Pharmaceuticals' Cash Per Share is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quoin Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Quoin Return On Asset vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Quoin Pharmaceuticals

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.56 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Quoin Pharmaceuticals

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.44
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Quoin Return On Asset Comparison

Quoin Pharmaceuticals is currently under evaluation in return on asset category among its peers.

Quoin Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Quoin Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Quoin Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Quoin Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Quoin Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-8.4 M-8 M
Income Before Tax-7.8 M-7.4 M
Net Loss-7.8 M-8.2 M
Net Interest Income709.2 K744.6 K
Net Loss-7.8 M-8.2 M
Total Other Income Expense Net642.9 K675 K
Net Loss-8.5 M-8.9 M
Income Tax Expense20.1 K21.2 K
Interest Income709.2 K744.6 K
Change To NetincomeM973.5 K
Net Loss(11.09)(10.53)
Income Quality 1.04  0.86 
Net Income Per E B T 0.90  0.65 

Quoin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Quoin Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Quoin Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Quoin Pharmaceuticals' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Quoin Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Use Investing Themes to Complement your Quoin Pharmaceuticals position

In addition to having Quoin Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds
Realty Funds Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.